Literature DB >> 11239879

Tamoxifen retinopathy in a male patient.

A C Yanyali1, K B Freund, J A Sorenson, J S Slakter, H M Wheatley.   

Abstract

PURPOSE: To report a case of tamoxifen retinopathy in a male patient.
METHODS: Case report. A 68-year-old man, who had received a cumulative tamoxifen dose of 60 g over 33 months for unresectable hepatocellular carcinoma, was evaluated.
RESULTS: A peculiar, bilateral, symmetric, inner retinal crystalline deposition associated with mild macular edema was discovered. No other ocular toxicity of tamoxifen was observed.
CONCLUSION: To our knowledge, this is the first report of tamoxifen retinopathy in a male.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11239879     DOI: 10.1016/s0002-9394(00)00781-9

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Tamoxifen maculopathy in a male patient.

Authors:  Shreyas Temkar; Amar Pujari; Divya Agarwal; Rohan Chawla
Journal:  BMJ Case Rep       Date:  2017-09-07

2.  Tamoxifen therapy conveys increased risk of developing a macular hole.

Authors:  Brendan G Cronin; Christopher K Lekich; Robert D Bourke
Journal:  Int Ophthalmol       Date:  2006-09-15       Impact factor: 2.031

3.  Macular Abnormalities Associated With 5α-Reductase Inhibitor.

Authors:  Yong Kyun Shin; Geun Woo Lee; Se Woong Kang; Sang Jin Kim; A Young Kim
Journal:  JAMA Ophthalmol       Date:  2020-07-01       Impact factor: 7.389

Review 4.  Ocular side effects of biological agents in oncology: what should the clinician be aware of?

Authors:  Tobias Hager; B Seitz
Journal:  Onco Targets Ther       Date:  2013-12-24       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.